Fact.MR – A Market Research and Competitive Intelligence Provider: As per the study by Fact.MR, the global aptamers market is projected to exhibit stellar growth at 21% CAGR during the forecast period between 2020 to 2025.
Sales of Aptamers to Increase by 3x with Growing Applications in Food & Beverage and Pharmaceutical Industry
In its latest report, Fact.MR offers a comprehensive analysis of the dynamics of the global aptamers market across the leading segments in terms of application, selection technique, material, and region. Besides, the report provides detailed information about the latest industry developments, future scope, and pipeline drugs.
Fact.MR – A Market Research and Competitive Intelligence Provider: As per the study by Fact.MR, the global aptamers market is projected to exhibit stellar growth at 21% CAGR during the forecast period between 2020 to 2025. Development of the chemical modification process to improve the therapeutic properties of aptamers is anticipated to drive the market in the upcoming years.
Aptamers are single-stranded RNA or DNA molecules that combine the benefits of proteins and low-molecular-weight substances. These have a tendency to form single-stranded loops and helices and thus can take a variety of shapes.
As per Fact.MR, aptamers are extensively used in the food and beverage industry. These are considered to be a significant measurement technique to detect bacteria present in food items. Hence, application of aptamers in food & beverage industry will fuel the growth in the market.
Want A Detailed Understanding of Market Functioning? Request for a Sample Here
https://www.factmr.com/connectus/sample?flag=S&rep_id=173
Besides, unlike antibodies, these molecules have high chemical and synthetic simplicity. Hence, these are likely to be used as biosensors to detect contaminants in the environment and food. For instance, Aptamer Group Ltd. extended its partnership with DeepVerge PLC in November 2021 to develop new Optimer binders. These will be used to detect viral particles within wastewater systems.
“Increasing usage of aptamers as diagnostics tools and drug-carriers is anticipated to create new growth opportunities for players in the global market. In addition, the rising number of research & development activities by key players to utilize these molecules as drugs is set to propel the growth,” says a Fact.MR analyst.
Key Takeaways:
- Based on selection technique, the SELEX technique segment is set to hold 80% of the market share as it is capable of determining the binding site of a RNA or protein.
- By application, the therapeutics segment is projected to generate the lion’s share on the back of increasing clinical trials to evaluate the aptamers for unique therapies.
- Based on material, the nucleic acid aptamers segment is expected to account for the largest global market share.
- The U.S. is likely to dominate the North America aptamers market owing to the increasing development of novel therapeutics by research institutes.
- Europe is anticipated to remain in the second position in terms of share driven by high demand for effective tools for the diagnosis of chronic diseases across the U.K. and Germany.
Growth Drivers:
- Increasing demand for FRELEX and MARAS methods owing to their ability to simplify the enzymatic steps is expected to boost the market.
- Rising investment by key players in the development of time- and cost-effective selection approaches is likely to propel the growth.
- High demand for aptamers as biosensors in the food and beverage industry to enhance the quality of products is set to augment the growth.
Restraints:
- Absence of oligonucleotide specific guidelines in developed countries to validate the general quality requirements of clinical trials may hinder the growth.
- Lack of regulatory standard for the safety of aptamers is estimated to hamper the growth in this market.
- Degradation of blood and biological media occurring because of the low molecular weight of aptamers may limit their adoption among manufacturers.
To gain in-depth insights on Aptamers Market, request methodology at
https://www.factmr.com/connectus/sample?flag=RM&rep_id=173
Competitive Landscape
Key players operating the global aptamers market are currently focusing on developing novel products to cater to the high demand from customers. Besides, a few other players are conducting extensive research & development activities by joining hands with educational institutions to introduce and commercialize new products.
For instance,
- December 2021: Researchers at the Stanford University School of Medicine developed a serum-stable RNA aptamer mainly for SARS-CoV-2 spike protein. Their study revealed that staging three aptamers together can enable very efficient neutralization of SARS-CoV-2 infection in cells and surge the binding efficiency to the low picomolar range.
- November 2021: Achiko AG, an IT service management company based in Switzerland, announced that it has accelerated the commercialization of both its Teman Sehat (Health Buddy) and AptameX. AptameX is the company’s superior rapid COVID-19 diagnostic test, while Teman Sehat is its sister digital passporting service.
- November 2021: A team of scientists at the Hefei Institutes of Physical Science (HFIPS) developed a state-of-the-art biosensor. It is based on the aptamer-combined surface-enhanced Raman spectroscopy (SERS). It will be used to detect inflammatory microRNA-122 (miR-122) in cell- secreted exosomes.
Key Players in the Aptamers Market Include:
- Raptamer Discovery Group
- Aptagen, LLC
- Aptamer Group
- Aptamer Sciences, Inc.
- SomaLogic Inc.
- Ophthotech Corporation
- Base Pair Biotechnologies, Inc.
- Others
More Valuable Insights on Aptamers Market
Fact.MR provides an unbiased analysis of the aptamers market, presenting historical demand data (2015-2019) and forecast statistics for the period from 2020-2025. The study divulges compelling insights on the global aptamers market with a detailed segmentation on the basis of:
Application
- Research
- Diagnostics
- Therapeutics
- Others
Selection Technique
- SELEX Technique
- Others
Material
- Nucleic Acid Aptamers
- Peptide Aptamers
Region
- North America
- Europe
- Asia Pacific
- Latin America
- Rest of the World
Key Questions Covered in Aptamers Market Report
- The report offers insight into the aptamers market demand outlook for 2020-2025.
- The market study also highlights projected sales growth for aptamers market between 2020 and 2025.
- Aptamers market survey identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry.
- Aptamers market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, joint ventures, collaborations or partnerships, and others.
Explore Fact.MR’s Coverage on the Healthcare Domain –
Oligonucleotide Synthesis Market Forecast - Biological and forensic applications of oligonucleotides include research, disease diagnostics, and treatments. Natural oligonucleotides have been widely employed as hybridization probes or affinity purification, gene assembly, and site-directed mutagenesis for selecting and determining DNA sequences. Furthermore, they are employed to suppress gene expression in in vitro diagnostic research. The increased use of oligonucleotides has increased the demand for synthetic chemistry technological advancements. As a result, several biotechnology and pharmaceutical businesses are working on developing newer and more advanced ways.
Biomarker Detection Systems Market Scope - Around the world, cardiovascular disorders, cancer, and neurological diseases are on the rise. Biomarker detection technologies have resulted as a result of this. Biomarkers are used to examine the formation of superfluous tissues and the damage to good tissues in such circumstances. This aids clinicians in determining the problem, disease stage, and drug to be prescribed to the patient. People prefer quick therapy over delayed treatment because cancer is the leading cause of death worldwide. Thus, biomarkers are commonly employed for cancer patients since they detect tissue growth at an early stage.
About Fact.MR
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology to even the most niche categories. 80% of Fortune 1000's trust us in critical decision making.
MarketNgage is powered by Fact.MR – our Unified Intelligence Engine, a revolutionary Market Research Subscription platform with a flexible pricing to suit your needs.
You can access all our healthcare research reports by signing up with MarketNgage’s Market Research Subscription with FREE credits. MarketNgage is powered by Fact.MR – A Fully integrated research solution for seamless single-window access Widest coverage on emerging markets, nascent products, and disruptive technologies.
Contact:
Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com